Epcoritamab (Tepkinly)
- Status:
- Red
- Decision Date:
- February 2024
Comments
NICE TA954: for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments. NHSE commissioned. (Decision date - April 2024)Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again